Business
PTC Therapeutics Launches Sixth Annual STRIVE Awards Program for Advocacy Organizations in Duchenne Muscular Dystrophy
- 28 initiatives improving the lives of those with Duchenne supported by the STRIVE Awards to date - - Grant funding proposals from non-profit patient
About this update from Ptc Therapeutics, Inc.
[{"type":"text","content":"- 28 initiatives improving the lives of those with Duchenne supported by the STRIVE Awards to date -\n - Grant funding proposals from non-profit patient advocacy organizations due April 30 -\n\n\nSOUTH PLAINFIELD, N.J., Feb. 18, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the launch of the sixth annual STRIVE grant awards program for Duchenne muscular dystrophy. The STRIVE Awards provide a grant to patient advocacy organizations to develop programs that make meaningful contributions to those in the rare disease community. The deadline for submissions is Thursday, April 30, and organizations can apply through an application form available here. Winners will be announced later this year on World Duchenne Awareness Day.\n\"The funding we received from the STRIVE Award last year has been fundamental in supporting our mission to acquire life-saving medical equipment, allowing us to deliver medical care and emotional support for those affected by Duchenne in northern Mexico,\" said Graciela Méndez Covarrubias, ENLACE. \"ENLACE is the only patient organization reaching those affected by Duchenne in the north Mexican states of Chihuahua and Nuevo Leon who, without our help, would not receive any kind of much-needed specialized care.\"\nSince its launch in 2015, the STRIVE program has supported almost 30 patient programs dedicated to improving the lives of those affected by Duchenne, even in the most remote locations around the world. Previous winning programs have improved access to diagnosis and treatment, provided emotional support for families, and developed opportunities for personal empowerment and independent living for those with Duchenne. Further details of all winning programs and a video showcasing some of the many extraordinary projects that have been supported by STRIVE over the last five years can be found here. \n\"After celebrating the five year milestone of the STRIVE Awards in 2019, we continue to be hugely proud of helping patient organizations from around the world provide vital support to the Duchenne community by bringing novel and pioneering projects to life,\" said Mary Frances Harmon, Senior Vice President, Corporate Relations, PTC Therapeutics. \"We know that the advocacy organizations supporting the Duchenne community still have so many more inspiring and creative initiatives, and...